The inconvenience of yearly flu shots prevents many people from getting them, while flu kills thousands of Americans annually. We need vaccines that will provide durable immunity and work against new variants. There is progress.
flu
The process of selecting viruses for the yearly flu vaccines is complex and inexact. For the 2023-2024 flu season, there is reason to be optimistic that the vaccines will provide good protection.
Although COVID-19 is giving us a temporary respite, influenza in humans and animals remains a serious threat. Its deadly H5N1 strain is spreading geographically and in more species of mammals, making the emergence of a pandemic strain more likely. We need to prepare.
COVID is still killing more than 1,000 Americans a week; long COVID causes prolonged misery; and a new, more transmissible subvariant of the SARS-CoV-2 virus is spreading.
Flu season is here. With COVID-19 still wreaking havoc in certain parts of the US, getting a flu shot is more important this year than ever before.
At the current time, influenza remains the far bigger threat to global public health than COVID-19. Though COVID-19 has a higher case-fatality rate, influenza infects far more people. Of course, that could change.
A new NBC News story warns us about the dangers of this year's flu. Although trite, the warning is at least reasonable. Until it isn't. Just another lame headline. Good for a scare and nothing else.
Do you want grandma to keep baking cookies? Well, she won't anymore if she dies from the flu. So go get your shot when the next flu season rolls around in October.
Many Americans hold beliefs about the flu vaccine that are at odds with the best available scientific evidence. For example, a recent study found that 43 percent of Americans believe that the seasonal flu vaccine can give us the flu. Scientific research strongly suggests that this is not true. Because most modern flu shots do not contain a live virus, the shot itself simply cannot get us sick.
New research from The Scripps Research Institute in San Diego found that protective IgG antibodies, one of five major classes of antibodies, may not be the most important ones when it comes to fighting off a flu infection. This insight may help make future flu vaccines and other treatments much more effective.
This flu season, one product is making its comeback: orange juice. Sales of OJ seem to have gotten a boost — after years of decline — due to consumers' fears of getting the dreaded illness.
But is dosing yourself with high amounts of Vitamin C warranted for this year's flu from hell?
It may be the height of the flu season but diagnosing flu remains a challenge for physicians.